v3.26.3
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended 33 Months Ended 141 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2026
Jul. 31, 2026
Dec. 31, 2025
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Cash and cash equivalents $ 148,238,000   $ 148,238,000   $ 148,238,000 $ 148,238,000   $ 199,278,000
Fair value of plan assets 500,000   500,000   $ 500,000 $ 500,000   500,000
Change in the estimated fair value of acquisition-related contingent consideration $ 0 $ 376,000 $ (22,480,000) $ 1,587,000        
Discount rate (as a percentage) 20.40%   20.40%   20.40% 20.40%    
Payments to acquire equity method investment         $ 30,000,000.0      
Investment in equity method investee $ 23,755,000   $ 23,755,000   $ 23,755,000 $ 23,755,000   25,956,000
Net revenues 30,907,000 27,085,000 89,471,000 88,258,000        
Net foreign exchange (losses) gains $ 33,000.0 600,000 $ 100,000 (700,000)        
IPR&D Technology                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Intangible asset, percentage of fair value in excess of carrying amount 6.00%   6.00%   6.00% 6.00%    
Indefinite-lived intangible assets $ 17,000,000.0   $ 17,000,000.0   $ 17,000,000.0 $ 17,000,000.0    
Related Party                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Financing receivable               300,000
Net revenues 1,900 $ 0 200,000 $ 0        
Sherlock Biosciences                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Earnout contingent consideration 5,233,000   5,233,000   5,233,000 5,233,000 $ 0 27,713,000
Change in the estimated fair value of acquisition-related contingent consideration     (22,480,000)     (17,900,000)    
Level I Instruments                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Cash and cash equivalents 12,808,000   12,808,000   12,808,000 12,808,000   13,114,000
Money Market Fund                
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                
Cash and cash equivalents $ 50,100,000   $ 50,100,000   $ 50,100,000 $ 50,100,000   $ 68,400,000